James Dinulos, MD
Dermatology · Portsmouth, NHNPI 1023037579
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,850 of the $9,285 with a category attached, or 95.3%. Merck accounts for 95.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $2,250 and has fallen 81.2% since, to $422 in 2025.
Across 15 payments — averaging $619.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$9K
- Integra Lifesciences Corporation$422
- Johnson & Johnson$13
What the payments were for
- Consulting fees$8,85095%
- Food & beverage$340%
- Other$4014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $8,850 |
| Integra Lifesciences Corporation | 3 | $422 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,285 in reported general payments places this provider in the 80th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $102,173 |
| Imiquimod | 56 | $2,506 |
| Metronidazole | 34 | $1,252 |
| Cephalexin | 39 | $823 |
| Clobetasol Propionate | 13 | $817 |
| Desonide | 12 | $551 |
| Mupirocin | 55 | $368 |
| Triamcinolone Acetonide | 20 | $308 |
| Ketoconazole | 11 | $162 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $151 |
| Amoxicillin | 72 | $108 |
| Clindamycin Hcl | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Portsmouth
- Abel JarellPortsmouth$2.3M
- Molly ChartierPortsmouth$6K
- Lisa ShermanPortsmouth$655
- Hagger AliPortsmouth$336
- Arthur MarkaPortsmouth$95
- Margaret StewartPortsmouth$86
- Andrew WerchniakPortsmouth$71
- Robert PosnickNashua$951K
- David PosnickNashua$203K
- Yulianna RussakLebanon$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.